DE60318237D1 - PHARMACEUTICAL COMPOSITIONS CONTAINING FLAVONOIDS AND MENTHOL - Google Patents

PHARMACEUTICAL COMPOSITIONS CONTAINING FLAVONOIDS AND MENTHOL

Info

Publication number
DE60318237D1
DE60318237D1 DE60318237T DE60318237T DE60318237D1 DE 60318237 D1 DE60318237 D1 DE 60318237D1 DE 60318237 T DE60318237 T DE 60318237T DE 60318237 T DE60318237 T DE 60318237T DE 60318237 D1 DE60318237 D1 DE 60318237D1
Authority
DE
Germany
Prior art keywords
menthol
pharmaceutical compositions
compositions containing
containing flavonoids
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60318237T
Other languages
German (de)
Other versions
DE60318237T2 (en
Inventor
Kurt Frimann Berg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IMMUPHARM AS
Original Assignee
IMMUPHARM AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IMMUPHARM AS filed Critical IMMUPHARM AS
Application granted granted Critical
Publication of DE60318237D1 publication Critical patent/DE60318237D1/en
Publication of DE60318237T2 publication Critical patent/DE60318237T2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to use of certain antiviral fragrances for reduction of viruses, in particular vira causing common cold. In one embodiment, the invention relates to pharmaceutical compositions comprising an antiviral fragrance, preferably menthol. Said compositions preferably also comprise one or more flavonoids. The invention also relates to treatment of common cold using said compositions.
DE60318237T 2002-10-24 2003-09-19 PHARMACEUTICAL COMPOSITIONS CONTAINING FLAVONOIDS AND MENTHOL Expired - Lifetime DE60318237T2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200201614 2002-10-24
DK200201614 2002-10-24
PCT/DK2003/000608 WO2004037237A1 (en) 2002-10-24 2003-09-19 Pharmaceutical compositions comprising flavonoids and menthol

Publications (2)

Publication Number Publication Date
DE60318237D1 true DE60318237D1 (en) 2008-01-31
DE60318237T2 DE60318237T2 (en) 2008-12-18

Family

ID=32116193

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60318237T Expired - Lifetime DE60318237T2 (en) 2002-10-24 2003-09-19 PHARMACEUTICAL COMPOSITIONS CONTAINING FLAVONOIDS AND MENTHOL

Country Status (11)

Country Link
US (2) US7585890B2 (en)
EP (1) EP1556021B1 (en)
CN (1) CN1717227A (en)
AT (1) ATE381323T1 (en)
AU (1) AU2003263162B2 (en)
CA (1) CA2511431A1 (en)
DE (1) DE60318237T2 (en)
DK (1) DK1556021T3 (en)
ES (1) ES2298618T3 (en)
PL (1) PL375621A1 (en)
WO (1) WO2004037237A1 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8481565B2 (en) 2004-12-27 2013-07-09 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
CA2601028C (en) * 2005-03-11 2014-05-27 Howard Florey Institute Of Experimental Physiology And Medecine Flavonoid compounds and uses thereof
FR2901705A1 (en) * 2006-06-01 2007-12-07 Persee Medica Soc Par Actions COMPOSITION FOR FIGHT AGAINST SNORING IN THE FORM OF A NASAL SPRAY
FR2901706A1 (en) * 2006-06-01 2007-12-07 Persee Medica Soc Par Actions NASAL AND ORAL COMPOSITIONS TO FIGHT THE SNOW
WO2008106979A2 (en) * 2007-03-02 2008-09-12 Immupharm A/S Pharmaceutical compositions comprising flavonoids and xylitol
US8952055B2 (en) * 2008-02-01 2015-02-10 Protectea, Ltd. Membrane fusion inhibitor
DE102009044974A1 (en) * 2009-07-23 2011-01-27 Henkel Ag & Co. Kgaa Use of dihydroquercetin and at least one amino acid to positively influence the natural pigmentation process
WO2011013825A1 (en) * 2009-07-31 2011-02-03 国立大学法人大阪大学 Antibacterial agent
US10080718B2 (en) 2010-09-01 2018-09-25 Try This First, Inc. Method of treating ear infections
US12016950B2 (en) 2010-09-01 2024-06-25 Try This First, Inc. Devices and methods for treating ear pain
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
US8691275B2 (en) 2011-01-28 2014-04-08 Zx Pharma, Llc Controlled-release melatonin compositions and related methods
US8568776B2 (en) 2011-02-11 2013-10-29 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
US8808736B2 (en) 2011-02-11 2014-08-19 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
US8911780B2 (en) 2011-02-11 2014-12-16 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
JP6062437B2 (en) 2011-09-09 2017-01-18 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム Smoking articles containing flavor delivery materials
CN102343083A (en) * 2011-10-17 2012-02-08 中国科学院成都生物研究所 Antivirus composition medicament
EP2641904A1 (en) * 2012-03-23 2013-09-25 Twincore Zentrum für Experimentelle und Klinische Infektionsforschung GmbH Flavone derivatives and their use
KR101426996B1 (en) 2012-07-24 2014-08-05 가톨릭대학교 산학협력단 Antiviral compositions comprising ethanol extract of Tetracera scandens and using the same
CN103156831A (en) * 2013-03-28 2013-06-19 南京中医药大学 Schizonepeta active component composition and medical application thereof
CA2881992C (en) * 2013-04-23 2016-11-22 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
US9034401B1 (en) 2014-01-23 2015-05-19 Matrixx Initiatives, Inc. Pharmaceutical compositions comprising plant extracts and methods for reducing duration of a common cold using same
US20150231112A1 (en) * 2014-02-14 2015-08-20 Brian Stanislaws Paul Nasal and sinus wash compositions and methods
CA2973217A1 (en) 2015-02-11 2016-08-18 The Fix, Llc Compositions and methods for combination ingredient delivery
WO2018022868A1 (en) * 2016-07-27 2018-02-01 Lowe Henry C Pi 4-kinase inhibitor as a therapeutic for viral hepatitis, cancer, malaria. autoimmune disorders and inflammation, and a radiosensitizer and immunosuppressant
CN106265630A (en) * 2016-10-13 2017-01-04 吉林大学 Amentoflavone application in research and development treatment pneumonia medicine
FR3057773B1 (en) * 2016-10-21 2020-06-19 Universite Claude Bernard Lyon 1 NOVEL ANTIVIRAL COMPOSITIONS FOR THE TREATMENT OF CORONAVIRUS-RELATED INFECTIONS
CN106963754B (en) * 2017-02-17 2021-05-04 深圳市太空科技南方研究院 Application of luteolin and analogues thereof in regulating biological rhythm
US11304968B2 (en) 2018-11-16 2022-04-19 Janssen Pharmaceutica Nv Pharmaceutical compositions comprising a hydroxyethylquercetin glucuronide
US10639294B2 (en) 2018-10-02 2020-05-05 Janssen Pharmaceutica Nv Pharmaceutical compositions comprising a hydroxyethylquercetin glucuronide metabolite
EP3920721A1 (en) * 2019-02-08 2021-12-15 Industrial Técnica Pecuaria S.A. Antioxidant composition comprising quercetagetin and gallic acid
MX2021015110A (en) * 2019-06-10 2022-02-22 Firebrick Pharma Ltd Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes.
WO2021191803A1 (en) * 2020-03-23 2021-09-30 Czap Research And Development, Llc Oral terpene cyclodextrin inclusion complex vehicles
US20230210877A1 (en) * 2020-05-29 2023-07-06 Vedicinals India Private Limited A Composition for Management of COVID-19 and Associated Disorders
WO2023133412A2 (en) * 2022-01-05 2023-07-13 Prophase Labs, Inc. Compositions having synergistic anti-viral action and methods for treating coronavirus

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4523589A (en) 1983-06-29 1985-06-18 Krauser Robert S Method and apparatus for treating ailments
US4889941A (en) * 1987-04-23 1989-12-26 Fisons Corporation Synthetic flavonoids as inhibitors of leukotrienes and 5-lipoxygenase
JPH0259513A (en) 1988-08-24 1990-02-28 Kiyuukiyuu Yakuhin Kogyo Kk Oral cavity mucosa-attaching type halitosis-preventing agent
FR2726469B1 (en) 1994-11-08 1996-12-13 Adir PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF FLAVONOIDS
DE19504832A1 (en) 1995-02-14 1996-08-22 Basf Ag Solid drug preparations
JP4135816B2 (en) 1995-11-24 2008-08-20 株式会社林原生物化学研究所 Propolis extract with improved water solubility
US5846557A (en) * 1996-03-20 1998-12-08 Cumberland Packing Corporation Chewing gum containing cough suppressing agent
KR20010013377A (en) 1997-06-04 2001-02-26 데이비드 엠 모이어 Mild, leave-on antimicrobial compositions
US6224872B1 (en) 1997-07-31 2001-05-01 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Composition
JPH11302184A (en) * 1998-04-21 1999-11-02 Taisho Pharmaceut Co Ltd Nasal composition
JP3763075B2 (en) 1998-04-24 2006-04-05 サンスター株式会社 Food composition, oral composition and pharmaceutical composition for prevention or treatment of periodontal disease
AU2182400A (en) * 1998-12-21 2000-07-12 Biovail International Ltd. Soft and chewy cough and cold relief composition
US6063383A (en) 1999-01-28 2000-05-16 Hsu; Wu-Ching Pharmaceutical suppository composites for fever and influenza and method of producing the composites
EP1100516B1 (en) 1999-06-03 2005-03-23 Johnson & Johnson Consumer France SAS Extracts of feverfew (tanacetum parthenium) against inflammatory disorders
JP2003504327A (en) 1999-07-08 2003-02-04 プレンダーガスト、パトリック、ティ． Use of flavones, coumarins and related compounds for the treatment of infectious diseases
FI20000004A0 (en) 2000-01-03 2000-01-03 Slk Foundation Flavonoidilääke ...
RS49778B (en) * 2000-06-15 2008-06-05 Ad. "Zdravlje" Farmaceutsko-Hemijska Industrija, PHARMACEUTICAL DISINFECTANTS BASED ON Na SALT OF USNIC ACID AND WHOLESOME HERBS AND METHOD FOR OBTAINING THEREOF
CN1280836A (en) * 2000-07-13 2001-01-24 贵阳高新顺业生物科技有限公司 Buccal rose lozenge and its preparing process
JP2002030000A (en) * 2000-07-17 2002-01-29 Saburo Yasuda Fundamental treatment for common cold
NZ524121A (en) 2000-07-28 2005-09-30 Immupharm Aps Compounds for treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
US6985719B2 (en) * 2000-12-21 2006-01-10 Nokia, Inc. Secure wireless backup mechanism
JP2002291441A (en) 2001-03-30 2002-10-08 Sunstar Inc Astragalin-containing food
JP2002363006A (en) 2001-06-05 2002-12-18 Nippon Eisei Center:Kk Antisepctic and insect proof agent composition
US6596313B2 (en) * 2001-08-06 2003-07-22 The Quigley Corporation Nutritional supplement and methods of using it
US6592896B2 (en) 2001-08-06 2003-07-15 The Quigley Corporation Medicinal composition and method of using it
US6579543B1 (en) 2002-02-22 2003-06-17 Jackie H. McClung Composition for topical application to skin

Also Published As

Publication number Publication date
CA2511431A1 (en) 2004-05-06
DK1556021T3 (en) 2008-04-28
US20060148726A1 (en) 2006-07-06
CN1717227A (en) 2006-01-04
EP1556021B1 (en) 2007-12-19
DE60318237T2 (en) 2008-12-18
WO2004037237A1 (en) 2004-05-06
ES2298618T3 (en) 2008-05-16
AU2003263162B2 (en) 2009-05-07
PL375621A1 (en) 2005-12-12
EP1556021A1 (en) 2005-07-27
US7671086B2 (en) 2010-03-02
ATE381323T1 (en) 2008-01-15
AU2003263162A1 (en) 2004-05-13
US20090227670A1 (en) 2009-09-10
US7585890B2 (en) 2009-09-08

Similar Documents

Publication Publication Date Title
DE60318237D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING FLAVONOIDS AND MENTHOL
ATE361084T1 (en) TOPICAL PHARMACEUTICAL COMPOSITIONS CONTAINING PROANTHOCYANIDINS, GLYCYRRHETINIC ACID AND TELMESTEINS FOR THE TREATMENT OF DERMATITIS
DE60331236D1 (en) ORAL COMPOSITIONS FOR THE TREATMENT OF DIABETES
DE60235083D1 (en) SUBSTITUTED TETRACYCLIN COMPOUNDS FOR THE TREATMENT OF MALARIA
BRPI0418251B8 (en) phosphonates, monophosphonamidates, bisphosphonamidates, and pharmaceutical composition comprising them
DE60232251D1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ASTHMA
EE200300475A (en) Tyrosine kinase inhibitors, pharmaceutical compositions containing them, and said compounds for use in the treatment of diseases
SE0100901D0 (en) New composition
ECSP045191A (en) "NEW PEPTIDES AS INHIBITORS OF THE SERINE PROTEASE NS3 OF THE VIRUS OF HEPATITIS C"
DE60209929D1 (en) SUCCINATE OF 5,8,14-TRIAZATETRACYCLOÄ10.3.1.0 2,11 .0 4,9 Ü-HEXADECA-2 (11), 3,5,7,9, -PENTAES AND PHARMACEUTICAL COMPOSITIONS
DK1594833T3 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
CY1108932T1 (en) Compounds 4- (heterocyclyl) -benzenesulfoximine for the therapeutic treatment of inflammatory diseases
CY1109361T1 (en) Substituted 4-Aminocyclohexanols
CY1110369T1 (en) NEW COOPERATIVE COMBINATION THAT INCLUDES Roflumilast And Formoterol
ATE486634T1 (en) CASPASE 3, 8, 9 OR 10 INHIBITORS IN COMBINATION WITH MEK INHIBITORS FOR THE TREATMENT OF INFLUENZA
DK1414473T3 (en) Oral compositions for the treatment of scalp diseases
CY1107231T1 (en) Substituted 4-Aminocyclohexanol derivatives
GT200200279A (en) ANTIBODY INHIBITING THE ACTIVITY OF THE PRECURSOR CELL FACTOR AND ITS USE FOR THE TREATMENT OF ASTHMA
HUP0400976A2 (en) Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides
ATE410154T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING 2,4-DICHLOROBENZYL ALCOHOL AND AMYLMETACRESOL
ATE353231T1 (en) PHARMACEUTICAL COMPOSITIONS
ATE458750T1 (en) ANTIVIRAL AGENTS FOR THE TREATMENT, CONTROL AND PREVENTION OF INFECTIONS CAUSED BY CORONAVIRUSES
BRPI0418749A (en) herbal composition
RS60604A (en) Carboxamidine derivatives and their use in the treatment of vascular diseases
BRPI0410967A (en) compounds, compositions and their uses for the treatment of virus infections of the family flaviviridae

Legal Events

Date Code Title Description
8364 No opposition during term of opposition